AYTU
Price
$2.34
Change
-$0.01 (-0.43%)
Updated
Sep 3 closing price
Capitalization
21.01M
PBH
Price
$66.91
Change
+$0.41 (+0.62%)
Updated
Sep 3 closing price
Capitalization
3.29B
56 days until earnings call
Interact to see
Advertisement

AYTU vs PBH

Header iconAYTU vs PBH Comparison
Open Charts AYTU vs PBHBanner chart's image
Aytu BioPharma
Price$2.34
Change-$0.01 (-0.43%)
Volume$30.95K
Capitalization21.01M
Prestige Consumer Healthcare
Price$66.91
Change+$0.41 (+0.62%)
Volume$630.79K
Capitalization3.29B
AYTU vs PBH Comparison Chart in %
Loading...
AYTU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AYTU vs. PBH commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AYTU is a Buy and PBH is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (AYTU: $2.34 vs. PBH: $66.91)
Brand notoriety: AYTU and PBH are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AYTU: 22% vs. PBH: 122%
Market capitalization -- AYTU: $21.01M vs. PBH: $3.29B
AYTU [@Pharmaceuticals: Generic] is valued at $21.01M. PBH’s [@Pharmaceuticals: Generic] market capitalization is $3.29B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.55B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AYTU’s FA Score shows that 0 FA rating(s) are green whilePBH’s FA Score has 0 green FA rating(s).

  • AYTU’s FA Score: 0 green, 5 red.
  • PBH’s FA Score: 0 green, 5 red.
According to our system of comparison, AYTU is a better buy in the long-term than PBH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AYTU’s TA Score shows that 6 TA indicator(s) are bullish while PBH’s TA Score has 4 bullish TA indicator(s).

  • AYTU’s TA Score: 6 bullish, 3 bearish.
  • PBH’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, AYTU is a better buy in the short-term than PBH.

Price Growth

AYTU (@Pharmaceuticals: Generic) experienced а +0.43% price change this week, while PBH (@Pharmaceuticals: Generic) price change was -0.07% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.02%. For the same industry, the average monthly price growth was +9.86%, and the average quarterly price growth was +87.27%.

Reported Earning Dates

PBH is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.02% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PBH($3.29B) has a higher market cap than AYTU($21M). AYTU YTD gains are higher at: 37.647 vs. PBH (-14.317). PBH has higher annual earnings (EBITDA): 362M vs. AYTU (10.6M). PBH has more cash in the bank: 140M vs. AYTU (18.2M). AYTU has less debt than PBH: AYTU (21.4M) vs PBH (1.04B). PBH has higher revenues than AYTU: PBH (1.12B) vs AYTU (81.7M).
AYTUPBHAYTU / PBH
Capitalization21M3.29B1%
EBITDA10.6M362M3%
Gain YTD37.647-14.317-263%
P/E RatioN/A15.71-
Revenue81.7M1.12B7%
Total Cash18.2M140M13%
Total Debt21.4M1.04B2%
FUNDAMENTALS RATINGS
AYTU vs PBH: Fundamental Ratings
AYTU
PBH
OUTLOOK RATING
1..100
1210
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
84
Overvalued
PROFIT vs RISK RATING
1..100
10043
SMR RATING
1..100
8562
PRICE GROWTH RATING
1..100
4085
P/E GROWTH RATING
1..100
6666
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AYTU's Valuation (42) in the Other Consumer Services industry is somewhat better than the same rating for PBH (84) in the Pharmaceuticals Other industry. This means that AYTU’s stock grew somewhat faster than PBH’s over the last 12 months.

PBH's Profit vs Risk Rating (43) in the Pharmaceuticals Other industry is somewhat better than the same rating for AYTU (100) in the Other Consumer Services industry. This means that PBH’s stock grew somewhat faster than AYTU’s over the last 12 months.

PBH's SMR Rating (62) in the Pharmaceuticals Other industry is in the same range as AYTU (85) in the Other Consumer Services industry. This means that PBH’s stock grew similarly to AYTU’s over the last 12 months.

AYTU's Price Growth Rating (40) in the Other Consumer Services industry is somewhat better than the same rating for PBH (85) in the Pharmaceuticals Other industry. This means that AYTU’s stock grew somewhat faster than PBH’s over the last 12 months.

AYTU's P/E Growth Rating (66) in the Other Consumer Services industry is in the same range as PBH (66) in the Pharmaceuticals Other industry. This means that AYTU’s stock grew similarly to PBH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AYTUPBH
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
54%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
62%
MACD
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
63%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
62%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
44%
Advances
ODDS (%)
Bullish Trend 11 days ago
75%
Bullish Trend 7 days ago
57%
Declines
ODDS (%)
Bearish Trend 18 days ago
89%
Bearish Trend 25 days ago
51%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
57%
Aroon
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
42%
View a ticker or compare two or three
Interact to see
Advertisement
AYTU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KMTS16.960.84
+5.21%
Kestra Medical Technologies, Ltd.
CBT80.39-0.42
-0.52%
Cabot Corp
TTWO238.86-2.09
-0.87%
Take-Two Interactive Software
GWH1.38-0.02
-1.43%
ESS Tech
ELA7.32-0.21
-2.79%
Envela Corp

AYTU and

Correlation & Price change

A.I.dvisor tells us that AYTU and AMPH have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AYTU and AMPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AYTU
1D Price
Change %
AYTU100%
-0.43%
AMPH - AYTU
29%
Poorly correlated
-4.61%
TRUFF - AYTU
22%
Poorly correlated
+2.58%
IMCC - AYTU
21%
Poorly correlated
-8.11%
PBH - AYTU
21%
Poorly correlated
+0.62%
BHC - AYTU
21%
Poorly correlated
-4.30%
More

PBH and

Correlation & Price change

A.I.dvisor indicates that over the last year, PBH has been loosely correlated with PAHC. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if PBH jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBH
1D Price
Change %
PBH100%
+0.62%
PAHC - PBH
44%
Loosely correlated
+4.46%
PRGO - PBH
34%
Loosely correlated
-0.68%
AMRX - PBH
32%
Poorly correlated
-0.42%
IRWD - PBH
32%
Poorly correlated
-5.73%
ELAN - PBH
29%
Poorly correlated
-2.80%
More